Table 3.
Group | (CC+CT) genotype |
Control subjects | 9.45 ± 2.51 (81) |
Cancer patients | 12.17 ± 3.90b (72) |
P < 0.002 vs control.
Group | (CC+CT) genotype |
Control subjects | 9.45 ± 2.51 (81) |
Cancer patients | 12.17 ± 3.90b (72) |
P < 0.002 vs control.